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ABSTRACT: Detection of nocturnal hypoxaemia, defined as a mean arterial oxygen 
saturation below 90 %, in normoxic or mildly hypoxic chronic obstructive pulmonary 
disease (COPD) patients seems clinically relevant, since this feature may precede 
pulmonary hypertension. Nocturnal studies are expensive and time-consuming 
procedures. The current study investigates to what extent it is possible to predict 
nocturnal hypoxaemia from daytime parameters.
Forty two COPD patients with a daytime arterial oxygen tension (PaOj) above 8 
kPa participated. Nocturnal oxygenation, daytime blood gas values, and ventilatory 
responses to hypercapnia were measured.
In 10 patients, enough desaturations occurred to qualify as nocturnal hypoxaemia. 
They had a significantly lower daytime Pao2 value, and a lower steady-state hypercapnic 
ventilatory response. They also smoked more often, and complained about daytime 
sleepiness. Multiple linear regression analysis demonstrated that daytime Pao2 (32%) 
was the best independent predictor. Sleepiness (12%), and number of cigarettes 
smoked (5%) also contributed independently, but in a minor way. Patients with a 
high daytime Pao2 (>11 kPa) did not develop nocturnal hypoxaemia.
The hypercapnic ventilatory response was used to distinguish nocturnal hypoxaemic 
from normoxaemic patients. Only patients with a low response (<3.5 /»inin ^kPa-1) 
appeared to run a risk of developing nocturnal hypoxaemia. The sensitivity of this 
test was 80%, and the specificity 70%.
It is concluded that daytime Pao2, hypercapnic ventilatory response and sleepiness 
are helpful in predicting nocturnal hypoxaemia.
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Episodes of oxygen desaturation may occur during 
sleep in patients with chronic obstructive pulmonary 
disease (COPD) [1—4]. In severe hypoxaemic COPD 
patients, such episodes are treated adequately when long­
term supplemental oxygen is admininistered [5-7]. COPD 
patients with mild daytime hypoxia or normoxia (Pao2 
>8 kPa) may also have transient oxygen desaturations 
during sleep, but they may not be apparent to physicians 
who only evaluate daytime blood gas values [8-10]. Never­
theless, this transient nocturnal hypoxaemia is accom­
panied by elevated pulmonary artery pressures [1-4, 8, 
11-17]. Moreover, it has been suggested that these 
transient elevations of the pulmonary artery pressure may 
lead to sustained pulmonary hypertension; and, finally, 
to the development of right heart failure [8,12,14,17-23]* 
In practice, it is not feasible to perform expensive 
nocturnal studies in all COPD patients who are mildly 
hypoxic or normoxic whilst awake, Therefore, it has 
been investigated whether daytime characteristics pre­
dict oxygenation during sleep in these patients. L ev i- 
V a le n s i  et al [8] showed a significant relationship between 
the baseline arterial oxygen saturation (Sao2) awake and 
nocturnal Sao2, in COPD patients with a Pao2 awake
above 8 kPa. F l e t c h e r  et al. [10] indicated that the de- 
saturators had lower Pao2 and higher arterial carbon diox­
ide tension (Paco2) values awake than nondesaturators. 
Furthermore, B r a d le y  et a l  [9] showed that daytime 
hypercapnia is a risk factor for the development of 
nocturnal hypoxaemia in COPD patients with mild day­
time hypoxaemia. However, all these parameters have 
appeared to be of little predictive value [8-10].
The purpose of the current study was to evaluate in 
COPD patients with mild daytime hypoxaemia or norm­
oxia (Pao2 >8 kPa), several daytime parameters as poss­
ible predictors of nocturnal hypoxaemia. The latter was 
defined as a mean nocturnal Sao2 below 90%.
Methods
Patients
Forty two patients with COPD (American Thoracic 
Society (ATS) criteria [5]) participated in this study. 
Inclusion criteria were: daytime Pao2 above 8.0 kPa; and
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Table 1. -  Characteristics of the COPD patients




Sex M/F 39/3 10/0 29/3
Age yrs 67 (7) 66 (6) 68 (7)
FEV, % pred 35 (10) 31 (10) 36 (11)
IVC % pred 80 (17) 71 (17) 82 (17)
TLC % pred 100 (22) 98 (32) 100 (18)
FRC % pred 131 (32) 140 (46) 128 (26)
RV % pred 146 (43) 163 (65) 141 (33)
HCVR /-min-^kPa-1 4.2 (4) 2.1 (2) 4.9 (4.2)*
Pao2 daytime kPa 9.8 (1.1) 9.1 (0.7) 10.0(1.1)*
Paco2 daytime kPa 5.4 (0.7) 5.8 (0.9) 5.3 (0.6)t
Body mass index 23 (3) 23 (4) 23 (3)
Smoking % 24 50 16+
Sleepiness % 24 60 12*
Mean noct. Sao2 % 91 (2.3) 88 (1.8) 92 (1.5)*
Lowest noct. Sao2 % 83 (6.7) 78 (5.7) 85 (5.9)*
Data are presented as mean (sd ). COPD: chronic obstructive 
pulmonary disease; Noct.: nocturnal; M: male; F: female; 
FEVp forced expiratory volume in one second; IVC: inspiratory 
vital capacity; TLC: total lung capacity; FRC: functional 
residual capacity; RV: residual volume; % pred: percentage 
of predicted; HCVR: hypercapnic ventilatory response; Pao2: 
arterial oxygen tension; Paco2: arterial carbon dioxide tension; 
Sao2: arterial oxygen saturation; body mass index: body weight 
(kg)/length2 (m). *: p <0.05; 14: 0.1 < p < 0.05.
a forced expiratory volume in one second (FEV,) value 
less than 65% of predicted [24]. The patient characteristics 
are shown in table 1. All patients were in a stable clinical 
condition, and received optimal bronchodilatory therapy. 
All medication was continued, except for benzodiazepines. 
Each subject gave informed consent. The study was 
approved by the Hospital Ethics Committee.
Techniques and protocol
Daytime, Arterial blood gas samples were obtained and 
pulmonary function parameters were determined. The 
ventilatory response to C 0 2 was measured using the steady- 
state method [25]. The patient was connected to a closed 
spirometric circuit by means of a mouthpiece. The end- 
tidal carbon dioxide tension (P e tco 2) level was increa­
sed 1 kPa, by adjusting a three-way valve, partially 
short-circuiting the C 02 absorber in the inspiratory limb 
of the circuit. Each level (baseline, 1 kPa above baseline) 
was studied over 5 ruin. The oxygen saturation level 
was maintained at 97% or more, by adding oxygen to 
the system.
The patients were questioned about the number of cig­
arettes they smoked daily. Daytime sleepiness was 
considered to be present when the sleepiness interfered 
with daily life, or had been noticed by other people.
Night-time. Oxygen saturation (Oxyshuttle, SensorMedics), 
chest-wall movements (Vitalog), oronasal airflow 
(thermistors), electromyogram (EMG) of the intercostal 
muscles, and electro-oculogram (EOG) were recorded 
from 10 p.m. until 6 a.m. The electromyogram of the 
2nd and 3rd parasternal intercostal muscles was recorded 
with surface electrodes, rectified and integrated. EMG- 
activity indicated breathing efforts.
The saturation data of the whole night were stored, 
digitized and analysed by a computer (Apple lie) to pro­
vide the mean and the lowest saturation of each night. 
Desaturation was defined as a decrease of more than 4% 
in oxygen saturation from the asleep baseline Sao2. The 
asleep baseline Sao2 was defined as the mean saturation 
15 min after falling asleep, lying in a horizontal posi­
tion, Nocturnal hypoxaemia was defined as a mean Sao2 
below 90%.
Central apnoea was defined as a cessation of airflow, 
thoracoabdominal movement, and activity of the inter­
costal muscles for at least 10 s. Obstructive apnoea was 
defined as absence of airflow for at least 10 s in the 
presence of thoracoabdominal movement and intercos­
tal muscle activity.
Indication for rapid eye movement (REM) sleep was 
shown when regular EOG activity was present.
Statistics
Statistical analyses to compare patient characteristics 
of the two groups were performed using the Wilcoxon 
two sample test and the Chi-squared test. Relationships 
between variables were evaluated with Spearman's rank 
correlation. Furthermore, partial correlations were 
determined by multiple linear regression analysis.
Results
In 33 of the 42 patients, one or more nocturnal des- 
aturations occurred. In 10 patients, mean nocturnal oxy­
gen saturation was below 90%. These 10 patients had 
significantly lower daytime Pao2 values and lower 
hypercapnic ventilatory responses than the 32 others 
(table 1). Furthermore, they complained more often 
about sleepiness. In one patient more than 10 obstructive 
apnoeaS‘h-] were found.
Table 2. -  Correlations between the mean nocturnal Sao2 and daytime characteristics
Sao2 Pao2 HCVR Cigarettes Sleepiness
daytime daytime /* min^kPa1 daily
% kPa n
Mean nocturnal Sao2 0.56* 0.58* 0.41* -0.49* -0.45*
*: p<0.05. None of the other daytime parameters was significantly correlated. For abbreviations see legend to table 1.
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Table 3. -  Results of the HCVR as a screening method 
to distinguish patients with nocturnal hypoxaemia (mean 
Sao2 <90%: positive test) and without nocturnal hypoxaemia 
(mean Sao2 >90%: negative test) (patients with a HCVR 





Sao2 <90% Sao2 >90%
Real
mean Sao2 <90% 10 8 2
mean Sao2 >90% 27 8 19
Total 37 16 21
Spearman's rank correlation showed a significant 
relationship between the mean nocturnal Sao2 and day­
time Sao2, daytime Pao2, the hypercapnie ventilatory 
response, and number of cigarettes smoked daily (table 
2), Presence of sleepiness also appeared to be signifi­
cantly different, indicating that sleepy persons had a lower 
mean nocturnal desaturation (Chi-squared test, p=0.01).
The partial correlations to the prediction of the mean 
nocturnal Sao2 were determined by multiple linear regres­
sion analysis. This showed that daytime Pao2 (32%), 
sleepiness (12%), and number of cigarettes smoked (5%), 
contributed independently to the total variance of 49% 
of the mean nocturnal Sao2. The prediction equation 
was: mean nocturnal Sao2=83.3 + 0.89 Pao2 - 2 sleep­
iness - 0.24 number of daily cigarettes, (r = a + bx + 
cy + dz), in which sleepiness was scored yes=l, or 
no=0.
No patients with a daytime Pao2 above 11,0 kPa 
developed nocturnal hypoxaemia. The large overlap in 
daytime Pao2 made it impossible to distinguish between 
patients with and without nocturnal hypoxaemia.
When the ability of the hypercapnic ventilatoiy resp­
onse to separate the nocturnal hypoxaemic and normox- 
aemic group was examined in the remaining patients with 
a daytime Pao2 below 11.0 kPa, a cut-off point for the 
response of 3.5 /«min-^kPa*1 was calculated to yield the 
highest sensitivity in the prediction of nocturnal hy poxae­
mia. The results of the hypercapnic ventilatory response 
as a screening test are shown in table 3. Two patients 
were falsely classified as not having nocturnal hypoxae­
mia. Eight patients were falsely classified as having 
nocturnal hypoxaemia. The sensitivity of this test was 
80%, and the specificity 70%. The negative predictive 
value was 91%, and the positive predictive value 50%.
Discussion
This study shows that nocturnal hypoxaemia was present 
in 10 of the 42 patients with normoxia or mild hypoxia. 
No patient with a Pao2 above 11.0 kPa developed nocturnal 
hypoxaemia.
The patients with nocturnal hypoxaemia had a signifi­
cantly lower Pao2 value, lower hypercapnic ventila­
tory response, and more complaints of sleepiness. The 
large overlap in daytime Pao2 made it impossible to pre­
dict nocturnal hypoxaemia in every individual patient.
However, the hypercapnic ventilatory response appeared 
to be helpful to indicate nocturnal hypoxaemia; and may, 
therefore, avoid redundant sleep studies. If sleep studies 
were performed only in those patients with a hypercap- 
nic ventilatory response below 3.5 /*min*I*kPa1, two of 
the nocturnal hypoxaemic patients (20%) would be miss­
ed, whereas 8 of the nocturnal normoxic patients (22%) 
would be measured unnecessarily. One of die two patients 
with unexpected nocturnal hypoxaemia had an obstruc­
tive sleep apnoea/hypopnoea syndrome. The negative 
predictive value of the test as a screening method in the 
current study was 91%, which is quite reasonable.
Our results are similar to those demonstrated in hypoxic 
COPD patients [26, 27]. Patients with higher C 02 
responses were not likely to develop nocturnal hypox­
aemia, whereas patients with lower ventilatory responses 
to C 0 2 might or might not have nocturnal hypoxaemia. 
It suggests that a blunted chemical drive by itself does 
not necessarily cause the nocturnal hypoxaemia, but 
allows the hypoxaemia, which is caused by other factors, 
such as ventilation-perfusion mismatching and changes 
in functional residual capacity [2], to persist. Other 
parameters, not measured in this study, but possibly 
influencing the nocturnal saturation are, for instance, 
respiratory muscle performance. Not only is the function­
ing of the central nervous respiratory organization impor­
tant in this respect, but also the properties of the effector 
organ; i.e. the respiratory muscles. It was shown by 
H eydra et al. [28] that nocturnal desaturations in COPD 
patients are also associated with respiratory muscle dys­
function.
The hypercapnic ventilatory response was measured 
by the steady-state method. In order to restrict the burden 
on patients due to C 02-loading, only two steps of the 
C 02-response curve were measured, A possible drawback 
of this method may be that it disregards the nonlinear­
ity in the C02-response curve at low Paco2 levels (dog­
leg). However, since most patients were normocapnic 
or hypercapnic, and since the step in Petco2 was rather 
high, the effect of the slope can only be of minor imp­
ortance. Furthermore, a nonlinearity of the C02 response 
curve is most prominent in hypoxic conditions. Since 
our patients were kept normoxic, a nonlinear C 02 response 
curve in normoxic and hypercapnic ranges is unlikely.
Only a small number of patients participated in this 
study, and the cut-off point for the hypercapnic ventila­
tory response had a low positive predictive value (50%), 
The validation of the test still has to be established in a 
prospective study.
The results of this study have some practical implica­
tions. Firstly, nocturnal hypoxaemia in patients with a 
daytime Pao2 above 11.0 kPa is very unlikely. Secondly, 
in COPD patients with a daytime Pao2 below 11.0 kPa 
and above 8.0 kPa, measurement of the hypercapnic ven­
tilatory response may be helpful as a screening test. Only 
in patients with responses below 3.5 /-mur^kPa-1, are 
nocturnal studies indicated.
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